20 May 2013
Keywords: actelion, gets, 145m, upfront, gsk, part, almorexant
Article | 21 July 2008
Actelion will receive an upfront payment of 150.0 million Swiss francs ($145.3 million) from UK drug major GlaxoSmithKline as part of an
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 July 2008
17 May 2013
© 2013 thepharmaletter.com